Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Lupin to promote Zymar to U.S. pediatricians

April 2, 2004

ThromboGenics and NuVue collaborate on plasmin products for visual disorders

March 16, 2004

Iquix receives FDA approval for bacterial corneal ulcer

March 15, 2004

VEGF Trap enters clinical development program

March 12, 2004

Positive results from Xibrom phase III studies

March 11, 2004

Additional phase III data in support of TTFC

March 10, 2004

Alrex safe for long-term treatment of seasonal allergic conjunctivitis

Feb. 24, 2004

Senju claims new chymase and/or tryptase inhibitors and their use

Feb. 11, 2004

Extension to Vitrase NDA review

Feb. 10, 2004

Inspire to conduct additional trial for diquafosol following FDA meeting

Feb. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...